Form 4: Verizon Executive Kyle Malady Reports Acquisition of Phantom Stock
SEC Form 4 Filing
EVP and Group CEO of Verizon Business, Kyle Malady, reports acquiring phantom stock units equivalent to 2,397 shares of common stock through a deferred compensation plan.
Summary
- On February 27, 2025, Kyle Malady, EVP and Group CEO-VZ Business at Verizon Communications Inc., reported acquiring 8,400.816 units of phantom stock.
- These phantom stock units are the economic equivalent of common stock and are settled in cash.
- The transaction was made through a deferred compensation plan.
- The price of the derivative security was $12.34.
- Following the transaction, Malady beneficially owns 374,935.693 derivative securities, including phantom stock acquired through dividend reinvestment.
- The reporting was filed on February 28, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to executive compensation, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to executive compensation and is typical for publicly traded companies like Verizon. It provides transparency into the holdings of key executives.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/27/2025 | Date of transaction: Kyle Malady acquired phantom stock. |
| 02/28/2025 | Date of filing: Form 4 filed by Evgeniya Berezkina, Attorney-in-fact for Kyle Malady. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.